Stock listing
NSE:THYROCARE Thyrocare Technologies Ltd Share Price
Home listing (NSE) of Thyrocare Technologies Ltd
Follow Thyrocare Technologies Ltd into a list and get an email when it puts out news.
Share price · NSE:THYROCARE
₹528.45 INR +24.85 (+4.9%)
Close on Nov 20, 2026
- Day range
- ₹504.00 – ₹554.70 INRNov 20, 2026
- Volume
- 9.10M sharesNov 20, 2026
- Market cap
- ₹84.11B INRAt the close on Nov 20, 2026 · price × 159.2M shares outstanding
- 52-week range
- ₹342.55 – ₹662.00 INRLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- ₹297.4M INRMedian day 283,091 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NSE:THYROCARE · Home | ₹528.45 INR | +24.85 (+4.9%) | 9,096,697 | ₹504.70 | ₹554.70 | ₹504.00 | ₹503.60 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NSE:THYROCARE · INR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| ₹528.45 | +24.85 | +4.9% | ₹504.70 | ₹554.70 | ₹504.00 | 9,096,697 | |
| ₹503.60 | -3.35 | -0.7% | ₹506.00 | ₹519.85 | ₹502.95 | 204,889 | |
| ₹506.95 | -2.70 | -0.5% | ₹513.80 | ₹518.00 | ₹505.00 | 329,559 | |
| ₹509.65 | +11.40 | +2.3% | ₹501.65 | ₹513.00 | ₹498.75 | 549,491 | |
| ₹498.25 | +10.25 | +2.1% | ₹488.00 | ₹500.20 | ₹487.10 | 222,106 | |
| ₹488.00 | -0.95 | -0.2% | ₹488.00 | ₹492.85 | ₹482.80 | 490,532 | |
| ₹488.95 | +3.65 | +0.8% | ₹486.00 | ₹494.45 | ₹485.05 | 199,098 | |
| ₹485.30 | -7.80 | -1.6% | ₹503.00 | ₹506.05 | ₹465.60 | 1,139,085 | |
| ₹493.10 | +3.35 | +0.7% | ₹489.75 | ₹496.45 | ₹484.45 | 216,499 | |
| ₹489.75 | -5.75 | -1.2% | ₹507.90 | ₹507.90 | ₹487.70 | 378,268 | |
| ₹495.50 | +12.60 | +2.6% | ₹486.55 | ₹498.90 | ₹479.75 | 290,070 | |
| ₹482.90 | +5.40 | +1.1% | ₹476.15 | ₹490.65 | ₹470.55 | 339,234 | |
| ₹477.50 | +21.20 | +4.6% | ₹460.00 | ₹480.95 | ₹444.35 | 702,547 | |
| ₹456.30 | -59.20 | -11.5% | ₹496.05 | ₹503.50 | ₹445.30 | 6,051,038 | |
| ₹515.50 | +21.00 | +4.2% | ₹501.00 | ₹520.80 | ₹498.70 | 1,005,085 | |
| ₹494.50 | +1.30 | +0.3% | ₹489.90 | ₹501.00 | ₹480.30 | 442,891 | |
| ₹493.20 | +22.55 | +4.8% | ₹475.35 | ₹496.80 | ₹472.25 | 618,789 | |
| ₹470.65 | +7.50 | +1.6% | ₹463.15 | ₹479.00 | ₹456.80 | 401,712 | |
| ₹463.15 | -12.35 | -2.6% | ₹467.25 | ₹482.00 | ₹454.50 | 267,871 | |
| ₹475.50 | +19.50 | +4.3% | ₹451.00 | ₹476.80 | ₹450.90 | 454,957 | |
| ₹456.00 | -13.75 | -2.9% | ₹470.40 | ₹470.40 | ₹450.75 | 613,682 | |
| ₹469.75 | -17.25 | -3.5% | ₹488.55 | ₹488.55 | ₹466.50 | 186,829 | |
| ₹487.00 | -0.40 | -0.1% | ₹489.90 | ₹489.90 | ₹480.70 | 218,198 | |
| ₹487.40 | -7.40 | -1.5% | ₹492.00 | ₹495.75 | ₹484.35 | 261,599 | |
| ₹494.80 | -4.20 | -0.8% | ₹499.00 | ₹501.90 | ₹491.80 | 253,081 | |
| ₹499.00 | -15.00 | -2.9% | ₹513.00 | ₹513.00 | ₹497.50 | 270,559 | |
| ₹514.00 | +16.70 | +3.4% | ₹498.05 | ₹519.00 | ₹494.90 | 465,533 | |
| ₹497.30 | -2.70 | -0.5% | ₹503.00 | ₹503.50 | ₹490.90 | 346,025 | |
| ₹500.00 | -13.40 | -2.6% | ₹515.50 | ₹515.50 | ₹498.00 | 869,553 | |
| ₹513.40 | -16.60 | -3.1% | ₹532.40 | ₹532.40 | ₹510.50 | 315,757 | |
| ₹530.00 | -7.00 | -1.3% | ₹542.00 | ₹544.60 | ₹528.50 | 156,551 | |
| ₹537.00 | +6.00 | +1.1% | ₹539.90 | ₹544.80 | ₹532.15 | 207,102 | |
| ₹531.00 | -4.00 | -0.7% | ₹531.80 | ₹538.55 | ₹519.30 | 223,853 | |
| ₹535.00 | -10.15 | -1.9% | ₹547.00 | ₹550.60 | ₹532.70 | 237,351 | |
| ₹545.15 | -4.35 | -0.8% | ₹549.95 | ₹555.55 | ₹545.00 | 105,491 | |
| ₹549.50 | -15.50 | -2.7% | ₹563.25 | ₹564.15 | ₹546.60 | 475,888 | |
| ₹565.00 | -0.20 | 0.0% | ₹566.20 | ₹570.80 | ₹556.60 | 129,345 | |
| ₹565.20 | -7.75 | -1.4% | ₹571.50 | ₹576.75 | ₹565.00 | 87,557 | |
| ₹572.95 | -5.05 | -0.9% | ₹580.00 | ₹584.75 | ₹572.35 | 146,553 | |
| ₹578.00 | +6.00 | +1.0% | ₹573.40 | ₹594.00 | ₹573.00 | 397,695 | |
| ₹572.00 | +16.70 | +3.0% | ₹555.35 | ₹575.00 | ₹551.10 | 350,735 | |
| ₹555.30 | -4.65 | -0.8% | ₹561.00 | ₹568.00 | ₹553.85 | 244,576 | |
| ₹559.95 | +16.95 | +3.1% | ₹542.05 | ₹560.00 | ₹536.10 | 145,357 | |
| ₹543.00 | -5.00 | -0.9% | ₹543.30 | ₹549.45 | ₹532.75 | 263,200 | |
| ₹548.00 | -4.70 | -0.9% | ₹552.70 | ₹556.90 | ₹542.05 | 194,375 | |
| ₹552.70 | -5.30 | -0.9% | ₹552.00 | ₹555.95 | ₹545.00 | 394,901 | |
| ₹558.00 | -11.40 | -2.0% | ₹568.90 | ₹569.55 | ₹553.65 | 303,873 | |
| ₹569.40 | -1.30 | -0.2% | ₹569.45 | ₹574.05 | ₹564.10 | 171,583 | |
| ₹570.70 | -7.10 | -1.2% | ₹573.10 | ₹577.00 | ₹566.60 | 161,195 | |
| ₹577.80 | +1.40 | +0.2% | ₹573.75 | ₹580.75 | ₹566.20 | 243,176 | |
| ₹576.40 | -1.60 | -0.3% | ₹575.05 | ₹581.90 | ₹573.35 | 137,365 | |
| ₹578.00 | +1.00 | +0.2% | ₹579.65 | ₹582.00 | ₹572.35 | 189,696 | |
| ₹577.00 | -14.00 | -2.4% | ₹590.60 | ₹590.80 | ₹572.40 | 344,774 | |
| ₹591.00 | -16.00 | -2.6% | ₹606.65 | ₹613.00 | ₹587.40 | 260,662 | |
| ₹607.00 | +19.00 | +3.2% | ₹584.35 | ₹613.00 | ₹577.30 | 647,414 | |
| ₹588.00 | +4.40 | +0.8% | ₹581.45 | ₹589.10 | ₹579.00 | 170,008 | |
| ₹583.60 | -22.80 | -3.8% | ₹605.20 | ₹605.20 | ₹577.75 | 396,389 | |
| ₹606.40 | +7.90 | +1.3% | ₹599.80 | ₹606.50 | ₹591.55 | 214,447 | |
| ₹598.50 | +14.50 | +2.5% | ₹586.00 | ₹599.00 | ₹583.00 | 276,112 | |
| ₹584.00 | +18.00 | +3.2% | ₹565.95 | ₹587.00 | ₹565.95 | 384,945 | |
| ₹566.00 | -1.00 | -0.2% | ₹566.85 | ₹575.95 | ₹563.10 | 330,982 | |
| ₹567.00 | -13.00 | -2.2% | ₹586.90 | ₹590.00 | ₹564.05 | 682,087 |
Splits
1 split · NSE:THYROCARE · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 3-for-1 | Split |
- Ticker
- NSE:THYROCARE
- Asset type
- Stock
- Sector
- Health care
- Industry
- Health care services
- Exchange
- NSE
- Currency
- INR
What changed lately
Latest news release · Oct 29, 2026
Thyrocare Technologies Limited has informed the Exchange regarding a press release dated October 29, 2026, titled "Press Release on Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30, 2026".
Latest deck · Oct 29, 2026
Q2 FY27 Earnings Presentation
Earnings · 35 slides
Latest news
Thyrocare Technologies Limited has informed the Exchange regarding a press release dated October 29, 2026, titled "Press Release on Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30, 2026".
Oct 29, 2026
Closed ₹456.30 (-11.5%) on Oct 30, 2026
Thyrocare Technologies Ltd Press Release Jul 23 2026
Jul 23, 2026
Closed ₹565.25 (+3.8%) on Jul 24, 2026
Press Release May 07 2026
May 7, 2026
Closed ₹486.00 (+2.9%) on May 8, 2026
Press Release Jan 28 2026
Jan 28, 2026
Closed ₹420.50 (-8.2%) on Jan 29, 2026
Thyrocare Technologies Ltd on 6ix
- Sector
- Health care
- Industry
- Health care services
- News releases
- 4 in the last 12 months · 11 in all · newest Oct 29, 2026 · oldest 2022
- Decks
- 48 decks · latest Oct 29, 2026
Where Thyrocare Technologies Ltd is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NSE:THYROCARE · Home listing · This page | NSE | India | INR |
| BSE:THYROCARE | BSE | India | INR |
Valuation
P/E 58.3× against a median of 15.7×: 7th lowest of 9 Health care services companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- ₹82.62B INR
- P/E
- 58.3×
- EV/sales
- 8.9×
- EV/EBITDA
- 27.6×
- Price/book
- 15.2×
- Gross margin
- 57.5%
- Operating margin
- 25.6%
- Net margin
- 15.5%
- Debt to equity
- 0.1×
- Beta
- No index for this market yet
Health care services: the 10 companies nearest in size, of 419 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Thyrocare Technologies Ltd · NSE:THYROCARE | US$907.7M | US$891.6M | 58.3× | 8.9× | 27.6× | 15.2× | 15.5% | 0.1× | n/a |
| Life Healthcare Group Holdings Limited · JSE:LHC | US$998.9M | US$1.21B | 4.5× | 0.8× | 26.3× | 1.6× | 15.4% | 0.4× | n/a |
| AdaptHealth Corp. · NASDAQ:AHCO | US$983.0M | US$2.79B | n/a | 0.8× | 23.8× | 0.8× | −11.8% | 1.5× | 0.24 |
| Ramsay Generale de Sante SA · EURONEXT:GDS | US$964.2M | US$5.05B | n/a | 0.8× | 7.3× | 0.8× | −0.9% | 3.6× | n/a |
| Guangxi LiuYao Group Co., Ltd. Class A · SSE:603368 | US$940.8M | US$646.9M | 10.1× | 0.2× | n/a | 0.8× | 2.9% | 0.1× | n/a |
| Clinica Baviera SA · BME:CBAV | US$932.5M | US$886.8M | 18.3× | 2.5× | 8.9× | 7.6× | 14.6% | 0.1× | n/a |
| Regis Healthcare Ltd. · ASX:REG | US$924.9M | US$812.5M | 25.1× | 0.9× | 11.5× | n/a | 4.1% | n/a | n/a |
| Suzhou MedicalSystem Technology Co., Ltd. Class A · SSE:603990 | US$921.4M | US$859.0M | 547× | 22.2× | n/a | 7.3× | 4.3% | 0.1× | n/a |
| Entero Healthcare Solutions Limited · NSE:ENTERO | US$894.2M | US$894.2M | 66.1× | 1.2× | 26.5× | 4.7× | 1.8% | 0.0× | n/a |
| MLP Saglik Hizmetleri AS Class B · BIST:MPARK | US$889.0M | US$791.8M | 6.7× | 0.6× | 2.1× | 1.0× | 10.0% | 0.2× | n/a |
| Terveystalo Oy Class A · OMXHEX:TTALO | US$823.9M | US$1.53B | 13.1× | 1.2× | 7.0× | 1.4× | 4.8% | 1.3× | n/a |
| Median of the others | US$928.7M | US$890.5M | 15.7× | 0.9× | 10.2× | 1.4× | 4.2% | 0.2× | 0.24 |
Forecasts
Analysts' consensus from EODHD, read Nov 9, 2026. Not 6ix's view and not investment advice.
- Price target
- 681.00 INR · Analysts' mean
- EPS, year to Mar 2027
- 13.30 · 4 analysts
- Revenue, year to Mar 2027
- 10.07B · 4 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Rahul Guha | Managing Director and Chief Executive Officer |
| Alok Kumar Jagnani | Chief Financial Officer |
Board
| Director | Role |
|---|---|
| Alok Kumar Jagnani | Chief Financial Officer |
| Anandh Sundar | Independent Director |
| Gaurav Verma | Non-Executive and Non-Independent Director |
| Harshil Jiten Vora | Independent Director |
| Indumati Gopinathan | Lead Independent Director |
| Nishant Amilal Shah | Independent Director |
| Prapti Ishwar Gilada | Independent Director |
| Uday Patel Kadam | Non-Executive and Non-Independent Director |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q2 2027 | Oct 29, 2026 · Before open | +4.3% |
| Q1 2027 | Jul 23, 2026 · Before open | −2.2% |
| Q4 2026 | May 7, 2026 · Before open | +2.1% |
| Q3 2026 | Jan 28, 2026 · Before open | +0.6% |
| Q1 2026 | Jul 23, 2025 · Before open | +1.5% |
| Q4 2025 | Apr 23, 2025 · Before open | −3.0% |
| Q3 2025 | Jan 23, 2025 · Before open | +1.3% |
| Q2 2025 | Oct 23, 2024 · Before open | +5.1% |
| Q1 2025 | Jul 23, 2024 · Before open | +0.8% |
| Q4 2024 | May 14, 2024 · After close | +1.8% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q3 2024 | Feb 1, 2024 · Before open | +1.6% |
| Q2 2024 | Oct 31, 2023 · Before open | +2.1% |
| Q1 2024 | Aug 1, 2023 · Before open | −0.3% |
| Q4 2023 | May 23, 2023 · After close | −1.3% |
| Q3 2023 | Feb 4, 2023 | −3.8% |
| Q2 2023 | Nov 11, 2022 · Before open | −0.3% |
| Q1 2023 | Aug 1, 2022 · Before open | +2.8% |
| Q3 2022 | Feb 12, 2022 · Before open | −7.9% |
| Quarter to Sep 30, 2021 | Nov 13, 2021 · Before open | +4.5% |
| Quarter to Jun 30, 2021 | Aug 12, 2021 · After close | −0.7% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q2 FY27 Earnings Presentation | Earnings | 35 slides | Oct 29, 2026 |
| Q1 FY27 Earnings Presentation | Earnings | 26 slides | Jul 23, 2026 |
| Q4 FY26 Earnings Presentation | Earnings | 31 slides | May 7, 2026 |
| Q3 FY26 Earnings Presentation | Earnings | 29 slides | Jan 28, 2026 |
| Q2 FY26 Earnings Presentation | Earnings | 28 slides | Oct 14, 2025 |
| Q1 FY26 Earnings Presentation | Earnings | 26 slides | Jul 23, 2025 |
| Q1 FY26 Earnings Presentation | Earnings | 25 slides | July 2025 |
| Q4 FY25 Earnings Presentation | Earnings | 30 slides | Apr 23, 2025 |
| Q3 FY25 Earnings Presentation | Earnings | 25 slides | Jan 23, 2025 |
| Q2 FY25 Earnings Presentation | Earnings | 28 slides | Oct 23, 2024 |
All 48 decks
Financials
Annual, in INR
Income statement
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 8.29B | 6.87B | 5.72B | 5.27B | 5.89B | 4.95B | 4.33B | 4.03B | 3.56B | 3.07B |
| Cost of revenue | 5.19B | 1.91B | 3.91B | 1.63B | 1.70B | 1.64B | 1.17B | 1.11B | 949.7M | 893.3M |
| Gross profit | 3.10B | 4.96B | 1.81B | 3.63B | 4.19B | 3.31B | 3.16B | 2.92B | 2.61B | 2.17B |
| Selling, general and administrative | 393.2M | 371.2M | 330.1M | 233.5M | 173.8M | 133.5M | 153.5M | 166.8M | 115.3M | 83.7M |
| Operating income | 2.07B | 1.35B | 958.4M | 865.5M | 2.01B | 1.41B | 1.42B | 1.29B | 1.26B | 1.01B |
| Depreciation and amortization | 585.8M | 552.6M | 470.1M | 387.1M | 338.7M | 302.8M | 319.1M | 261.7M | 201.0M | 180.5M |
| EBITDA | 2.65B | 1.90B | 1.43B | 1.25B | 2.35B | 1.71B | 1.74B | 1.55B | 1.46B | 1.19B |
| Interest expense | 28.0M | 30.5M | 55.3M | 48.3M | 23.7M | 8.70M | 18.5M | 6.10M | 4.40M | 1.95M |
| Income before tax | 2.13B | 1.45B | 955.9M | 885.9M | 2.28B | 1.52B | 1.40B | 1.38B | 1.45B | 1.09B |
| Income tax | 500.3M | 546.9M | 264.9M | 242.3M | 515.8M | 393.2M | 520.1M | 529.2M | 517.2M | 384.5M |
| Net income | 1.63B | 915.1M | 707.6M | 644.9M | 1.76B | 1.13B | 884.0M | 851.4M | 932.8M | 709.6M |
| Earnings per share, basic | 10.24 | 17.08 | 13.34 | 12.17 | 33.24 | 21.37 | 16.70 | 15.91 | 17.32 | 13.22 |
Balance sheet
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 383.2M | 176.8M | 93.6M | 177.7M | 136.3M | 132.0M | 87.0M | 49.1M | 98.2M | 115.9M |
| Short-term investments | 1.93B | 1.74B | 1.67B | 1.33B | 1.25B | 1.04B | 713.9M | 793.3M | 1.02B | 1.01B |
| Receivables | 738.8M | 821.8M | 441.6M | 856.7M | 944.8M | 513.5M | 163.0M | 124.6M | 99.1M | 186.2M |
| Inventory | 484.6M | 537.9M | 475.2M | 302.3M | 344.3M | 249.6M | 206.2M | 180.8M | 170.5M | 145.0M |
| Current assets | 3.72B | 3.38B | 2.79B | 2.73B | 2.70B | 2.40B | 1.52B | 1.36B | 1.42B | 1.46B |
| Property, plant and equipment | 1.98B | 2.04B | 1.94B | 1.87B | 1.60B | 1.73B | 1.87B | 1.90B | 1.69B | |
| Goodwill | 1.08B | 1.08B | 1.04B | 1.00B | 1.00B | 1.00B | 1.00B | 1.07B | 1.07B | 1.07B |
| Total assets | 7.47B | 6.93B | 6.44B | 6.33B | 6.08B | 5.46B | 4.69B | 4.75B | 4.79B | 4.36B |
| Accounts payable | 653.7M | 762.1M | 401.1M | 239.9M | 165.3M | 250.1M | 218.6M | 75.1M | 11.6M | 6.79M |
| Current liabilities | 1.10B | 1.22B | 904.8M | 771.0M | 645.2M | 951.0M | 816.9M | 205.9M | 202.9M | 164.2M |
| Long-term debt | 0 | 109.1M | 0 | 0 | 25.0M | 25.0M | 100.8M | 72.5M | ||
| Total debt | 506.9M | 246.8M | 423.4M | 233.1M | 207.0M | -7.00M | 124.4M | 70.6M | 106.2M | 72.5M |
| Total liabilities | 1.61B | 1.46B | 1.16B | 975.0M | 810.9M | 1.19B | 1.03B | 396.0M | 357.0M | 290.2M |
| Shareholders' equity | 5.86B | 5.47B | 5.27B | 5.34B | 5.27B | 4.27B | 3.67B | 4.35B | 4.43B | 4.07B |
| Shares outstanding | 159.2M | 53.6M | 53.0M | 53.0M | 53.0M | 53.0M | 52.9M | 53.5M | 53.8M | 53.7M |
Cash flow
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 2.16B | 1.91B | 1.68B | 1.29B | 1.13B | 1.16B | 1.68B | 1.00B | 1.07B | 894.4M |
| Capital spending | -208.8M | -448.9M | -615.8M | -436.5M | -378.3M | -282.6M | -99.0M | -402.5M | -436.5M | -363.6M |
| Free cash flow | 1.95B | 1.46B | 1.06B | 856.6M | 755.8M | 877.7M | 1.58B | 600.6M | 633.8M | 530.8M |
| Cash from investing | -260.8M | -525.2M | -912.8M | -389.9M | -235.7M | -502.3M | 9.50M | -115.9M | -432.2M | -415.1M |
| Cash from financing | -1.70B | -1.30B | -848.0M | -861.8M | -894.1M | -615.7M | -1.65B | -936.3M | -638.8M | -485.0M |
| Dividends paid | -1.48B | -953.1M | -952.7M | -793.6M | -793.1M | -528.4M | -1.32B | -268.6M | -537.2M | -402.9M |
| Share buybacks | 400.0K | 200.0K | -55.3M | -55.3M | 24.8M | 25.0M | -630.0M | |||
| Change in cash | 503.1M | 83.8M | -84.7M | 41.4M | 4.30M | 42.4M | 38.0M | -49.1M | -640.0K | -5.67M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| Thyrocare Technologies Limited has informed the Exchange regarding a press release dated October 29, 2026, titled "Press Release on Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30, 2026". | Oct 29, 2026 | Results | NSE India |
| Thyrocare Technologies Ltd Press Release Jul 23 2026 | Jul 23, 2026 | Results | NSE India |
| Press Release May 07 2026 | May 7, 2026 | Other filings | NSE India |
| Press Release Jan 28 2026 | Jan 28, 2026 | Other filings | NSE India |
| Press Release Oct 14 2025 | Oct 14, 2025 | Other filings | NSE India |
| Press Release Jul 23 2025 | Jul 23, 2025 | Results | NSE India |
| Press Release Apr 23 2025 | Apr 23, 2025 | Quarterly report | NSE India |
| Press Release Jan 23 2025 | Jan 23, 2025 | Other filings | NSE India |
| Press Release Oct 23 2024 | Oct 23, 2024 | Other filings | NSE India |
| Press Release Aug 30 2024 | Aug 30, 2024 | Other filings | NSE India |
All 11 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| Press Release Feb 07 2022 | Feb 7, 2022 | Other filings | NSE India |
Cap table
Built by 6ix from Thyrocare Technologies Ltd’s releases
- Common shares
- 159,165,315
- Fully diluted
- 159,165,315
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 159,165,315 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 159,165,315 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Alok Kumar Jagnani | Chief Financial Officer · Since at least Nov 6, 2026 |
| Anandh Sundar | Independent Director · Since at least Nov 6, 2026 |
| Gaurav Verma | Non-Executive and Non-Independent Director · Since at least Nov 6, 2026 |
| Harshil Jiten Vora | Independent Director · Since at least Nov 6, 2026 |
| Indumati Gopinathan | Lead Independent Director · Since at least Nov 6, 2026 |
| Nishant Amilal Shah | Independent Director · Since at least Nov 6, 2026 |
| Prapti Ishwar Gilada | Independent Director · Since at least Nov 6, 2026 |
| Rahul Guha | Managing Director and Chief Executive Officer · Since at least Nov 6, 2026 |
| Uday Patel Kadam | Non-Executive and Non-Independent Director · Since at least Nov 6, 2026 |
Log in to ask 6ix AI your own questions about Thyrocare Technologies Ltd.